GEORGE HAGAN JACKSON
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology GLEN ALLEN, VA NPI 1124369863
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology VA EMD Serono, Inc. All categories
General Payments — all program years on this page
$99.74
- Category: General Payments
- Program years: PY2018
- Record count: 7
- As of (CMS publication): 2026-01-23
Latest program year (PY2018): $99.74 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2018) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $99.74 | 7 |
By paying entity
Latest program year (PY2018) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| EMD Serono, Inc. | $29.72 | 2 |
| Avanir Pharmaceuticals, Inc. | $22.39 | 1 |
| Supernus Pharmaceuticals, Inc. | $13.61 | 1 |
| Teva Pharmaceuticals USA, Inc. | $12.68 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $10.84 | 1 |
| Amgen Inc. | $10.50 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2018 | $99.74 | 7 |
Records — PY2018 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 565134079 | Avanir Pharmaceuticals, Inc. | $22.39 | 03/01/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 569041385 | Amgen Inc. | $10.50 | 05/01/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 608308533 | Novartis Pharmaceuticals Corporation | $10.84 | 02/22/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 614109703 | Teva Pharmaceuticals USA, Inc. | $12.68 | 04/17/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 615010613 | EMD Serono, Inc. | $14.47 | 03/08/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 615036657 | EMD Serono, Inc. | $15.25 | 05/03/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 615729009 | Supernus Pharmaceuticals, Inc. | $13.61 | 02/08/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2018_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.